JP2024530023A5 - - Google Patents
Info
- Publication number
- JP2024530023A5 JP2024530023A5 JP2024506879A JP2024506879A JP2024530023A5 JP 2024530023 A5 JP2024530023 A5 JP 2024530023A5 JP 2024506879 A JP2024506879 A JP 2024506879A JP 2024506879 A JP2024506879 A JP 2024506879A JP 2024530023 A5 JP2024530023 A5 JP 2024530023A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- mutation
- aav
- seq
- vector system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163230046P | 2021-08-05 | 2021-08-05 | |
| US63/230,046 | 2021-08-05 | ||
| PCT/US2022/074611 WO2023015297A1 (en) | 2021-08-05 | 2022-08-05 | Engineered muscle targeting compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024530023A JP2024530023A (ja) | 2024-08-14 |
| JP2024530023A5 true JP2024530023A5 (cg-RX-API-DMAC7.html) | 2025-08-14 |
Family
ID=85156332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506879A Pending JP2024530023A (ja) | 2021-08-05 | 2022-08-05 | 操作された筋肉標的化組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250090688A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4381078A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024530023A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118076743A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022324116A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3230479A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023015297A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| WO2024173802A2 (en) * | 2023-02-17 | 2024-08-22 | Biogen Ma Inc. | Rgd-containing peptides for delivering payloads |
| WO2024238807A2 (en) * | 2023-05-16 | 2024-11-21 | Affinia Therapeutics Inc. | Recombinant aavs with improved tropism and specificity |
| CN121203037A (zh) * | 2025-09-26 | 2025-12-26 | 北京因诺惟康医药科技有限公司 | 基于整合素改造的特异性靶向心脏及肌肉的aav9优势突变体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020368539A1 (en) * | 2019-10-16 | 2022-04-28 | Massachusetts Institute Of Technology | Engineered muscle targeting compositions |
| KR20230053591A (ko) * | 2020-07-22 | 2023-04-21 | 더 브로드 인스티튜트, 인코퍼레이티드 | 조작된 근육 표적화 조성물 |
-
2022
- 2022-08-05 JP JP2024506879A patent/JP2024530023A/ja active Pending
- 2022-08-05 WO PCT/US2022/074611 patent/WO2023015297A1/en not_active Ceased
- 2022-08-05 EP EP22854125.6A patent/EP4381078A4/en active Pending
- 2022-08-05 CA CA3230479A patent/CA3230479A1/en active Pending
- 2022-08-05 CN CN202280066328.6A patent/CN118076743A/zh active Pending
- 2022-08-05 US US18/294,594 patent/US20250090688A1/en active Pending
- 2022-08-05 AU AU2022324116A patent/AU2022324116A1/en active Pending